Three-step synthetic procedure to prepare dolutegravir, cabotegravir, and bictegravir
Dolutegravir, cabotegravir, and bictegravir are three integrase inhibitors, which were used for HIV-1 in the clinic. In this paper, a continuous three-step synthetic strategy was developed to prepare dolutegravir, cabotegravir, and bictegravir in a better yield, compared to the initial step-by-step...
Main Authors: | Xianheng Wang, Song Chen, Hanqi Cui, Yuqi He, Changkuo Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-04-01
|
Series: | Green Chemistry Letters and Reviews |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/17518253.2022.2057200 |
Similar Items
-
A Pharmacokinetic Dose-Optimization Study of Cabotegravir and Bictegravir in a Mouse Pregnancy Model
by: Haneesha Mohan, et al.
Published: (2022-08-01) -
Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
by: Chang Huang, et al.
Published: (2023-03-01) -
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
by: Alexa Vyain Zhao, et al.
Published: (2022-10-01) -
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
by: Hernando Knobel, et al.
Published: (2023-12-01) -
A possible case of bictegravir-associated severe unconjugated hyperbilirubinemia
by: Kanak Parmar, et al.
Published: (2023-01-01)